Association of extreme first-trimester free human chorionic gonadotropin-β, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes

This publication has 18 references indexed in Scilit:

• Predicting complications of pregnancy with first‐trimester maternal serum free‐βhCG, PAPP‐A and inhibin‐A
  Prenatal Diagnosis, 2003
• First-Trimester Screening for Trisomies 21 and 18
  New England Journal of Medicine, 2003
• One‐stop clinic for assessment of risk for trisomy 21 at 11–14 weeks: a prospective study of 15 030 pregnancies
  Ultrasound in Obstetrics & Gynecology, 2002
• Decreased first trimester PAPP‐A is a predictor of adverse pregnancy outcome
  Prenatal Diagnosis, 2002
• First trimester maternal serum free β human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications
  BJOG: An International Journal of Obstetrics and Gynaecology, 2000
• First-Trimester down syndrome screening using dried blood biochemistry and nuchal translucency
  Obstetrics & Gynecology, 2000
• Second-trimester maternal serum marker screening: Maternal serum α-fetoprotein, β-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome
  American Journal of Obstetrics and Gynecology, 1999
• 1994–1996 U.S. Singleton Birth Weight Percentiles for Gestational Age by Race, Hispanic Origin, and Gender
  Maternal and Child Health Journal, 1999
• Prediction of adverse perinatal outcome by maternal serum screening for down syndrome in an asian population
  Published by Wolters Kluwer Health ,1998
• Human placental lactogen and pregnancy‐associated plasma protein A in first trimester and subsequent fetal growth
  Acta Obstetricia et Gynecologica Scandinavica, 1995